▶ 調査レポート

世界の臨床試験キット市場

• 英文タイトル:Market Study on Clinical Trial Kits: Direct-to-Patient Clinical Trials Shaping the Clinical Trial Kits Demand

Persistence Market Researchが調査・発行した産業分析レポートです。世界の臨床試験キット市場 / Market Study on Clinical Trial Kits: Direct-to-Patient Clinical Trials Shaping the Clinical Trial Kits Demand / MRC2303A075資料のイメージです。• レポートコード:MRC2303A075
• 出版社/出版日:Persistence Market Research / 2022年12月16日
• レポート形態:英文、PDF、250ページ
• 納品方法:Eメール
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Site Licence¥1,140,000 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,590,000 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社発行の当調査レポートでは、世界の臨床試験キット市場の現状について調査・分析し、エグゼクティブサマリー、市場概要、市場背景、市場分析・予測、市場構造分析、競争分析、仮定、調査手法などの構成でまとめております。セグメント分析では、サービス別(キッティングソリューション、物流)、フェーズ別(フェーズI、フェーズII、フェーズIII、フェーズIV)、地域別(北米、中南米、ヨーロッパ、アジア太平洋、中東/アフリカ)の情報が含まれています。なお、当市場の主要企業には、Azenta Life Sciences、Q2 Solutions、Patheon (Thermo fisher scientific)、LabCorp drug development、Charles River Laboratories、LabConnect、Almac group、Precision medicine group、Cerba research、Alpha Laboratories Ltd、Marken SAS、Clinigenなどが含まれています。
・エグゼクティブサマリー
・市場概要
・市場背景
・市場分析・予測

・世界の臨床試験キット市場規模: サービス別
- キッティングソリューションサービスの市場規模
- 物流サービスの市場規模

・世界の臨床試験キット市場規模:フェーズ別
- フェーズIの市場規模
- フェーズIIの市場規模
- フェーズIIIの市場規模
- フェーズIVの市場規模

・世界の臨床試験キット市場規模:地域別
- 北米の臨床試験キット市場規模
- 中南米の臨床試験キット市場規模
- ヨーロッパの臨床試験キット市場規模
- アジア太平洋の臨床試験キット市場規模
- 中東/アフリカの臨床試験キット市場規模

・市場構造分析
・競争分析
・仮定
・調査手法

Global Clinical Trial Kits Market: Global Industry Analysis 2015-2021 and Opportunity Assessment 2022-2032

A recent market study published by Persistence Market Research on the Clinical Trial Kits Market offers global industry analysis for 2015-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The global Clinical Trial Kits Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Service Type

Kitting Solutions
Drugs Kits
Sample Collection Kits
Logistics
Transportation
Warehousing & Storage
Other Logistics

By Phase

Phase I
Phase II
Phase III
Phase IV

By Region

North America
Latin America
Europe
Asia Pacific
Middle East and Africa (MEA)

Report Chapters

Chapter 01 – Executive Summary
The executive summary of the Clinical Trial Kits Market includes the global market analysis, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Clinical Trial Kits Market.

Chapter 02 – Market Overview
Readers can find the detailed segmentation and definition of the Clinical Trial Kits Market in this chapter, which will help them understand basic information about the Clinical Trial Kits Market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the Clinical Trial Kits Market report.

Chapter 03 – Market Background
The associated industry assessment of the global Clinical Trial Kits Market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Clinical Trial Kits Market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis, social media sentiment analysis, and consumer behavior analysis for the market. It offers provides key market dynamics of the Clinical Trial Kits Market, which include drivers, restraints, and opportunities.

Chapter 04 – Global Clinical Trial Kits Market Demand Analysis 2015-2021 and Forecast, 2022-2032
This section provides detailed analysis of the historical custom Clinical Trial Kits Market value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2021–2022) and an absolute opportunity for the forecast period (2022–2032).

Chapter 05 – Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, by Service Type
Based on Service Type, the Clinical Trial Kits Market is segmented into Kitting Solutions (Drugs kits, Sample collection kits), Logistics (Transportation, Warehousing & Storage, Other Logistics). In this chapter, readers can find market attractiveness analysis, based on Service Type.

Chapter 06 – Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, by Phase
This chapter provides details about the Clinical Trial Kits Market on the basis of phase which is segmented into Phase I, Phase II, Phase III, Phase IV, along with market attractiveness analysis.

Chapter 07 – Global Clinical Trial Kits Market Analysis 2015-2021 and Opportunity Assessment 2022-2032 by Region
This chapter explains how the Clinical Trial Kits Market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa (MEA).

Chapter 08 – North America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Clinical Trial Kits Market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth in the North America region.

Chapter 09 – Latin America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Clinical Trial Kits Market in the Latin America region. This chapter also includes growth prospects of the Clinical Trial Kits Market in leading LATAM countries such as Brazil, Mexico, Argentina and Rest of Latin America.

Chapter 10 – Europe Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
Important growth prospects of the Clinical Trial Kits Market in several countries such as Germany, Italy, France, U.K., Spain, Belgium and Rest of Europe are included in this chapter.

Chapter 11 –Asia Pacific Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Clinical Trial Kits Market in the Asia Pacific region, along with a country-wise assessment that includes China, Japan, South Korea, India, Australia and rest of Asia Pacific. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.

Chapter 12 – Middle East and Africa Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032
This chapter offers insights into how the Clinical Trial Kits Market is expected to grow in major countries in the MEA region such as South Africa, Saudi Arabia, UAE and Rest of MEA, during the forecast period 2022-2032.

Chapter 13 – Key Countries Clinical Trial Kits Market Analysis
This chapter offers insights into how the Clinical Trial Kits Market is expected to grow in key countries such as U.S., Canada, Brazil, Mexico, Argentina, Germany, Italy, France, U.K., Spain, Belgium, China, Japan, South Korea, India, Australia, Saudi Arabia, South Africa, U.A.E. during the forecast period 2022-2032.

Chapter 14 – Market Structure Analysis
In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the Clinical Trial Kits Market along with their market presence analysis by region and product portfolio.

Chapter 15 – Competition Analysis
In this chapter, readers can find a comprehensive list of manufacturers/ players in Clinical Trial Kits Market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report include Azenta Life Sciences, Q2 Solutions, Patheon, LabCorp drug development, Charles River Laboratories, LabConnect, Almac group, Precision medicine group, Cerba research, Alpha Laboratories Ltd, Marken SAS, Clinigen, among others.

Chapter 16 – Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Clinical Trial Kits Market report.

Chapter 17 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the Clinical Trial Kits Market.

レポート目次

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2015-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Service Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Service Type, 2015-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Service Type, 2022-2032

        5.3.1. Kitting Solutions

            5.3.1.1. Drugs kits

            5.3.1.2. Sample collection kits

        5.3.2. Logistics

            5.3.2.1. Transportation

            5.3.2.2. Warehousing & Storage

            5.3.2.3. Other Logistics

    5.4. Y-o-Y Growth Trend Analysis By Service Type, 2015-2021

    5.5. Absolute $ Opportunity Analysis By Service Type, 2022-2032

6. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Phase

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Mn) Analysis By Phase, 2015-2021

    6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Phase, 2022-2032

        6.3.1. Phase I

        6.3.2. Phase II

        6.3.3. Phase III

        6.3.4. Phase IV

    6.4. Y-o-Y Growth Trend Analysis By Phase, 2015-2021

    6.5. Absolute $ Opportunity Analysis By Phase, 2022-2032

7. Global Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2015-2021

    7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Europe

        7.3.4. Asia Pacific

        7.3.5. MEA

    7.4. Market Attractiveness Analysis By Region

8. North America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. U.S.

            8.2.1.2. Canada

        8.2.2. By Service Type

        8.2.3. By Phase

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Service Type

        8.3.3. By Phase

    8.4. Key Takeaways

9. Latin America Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Service Type

        9.2.3. By Phase

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Service Type

        9.3.3. By Phase

    9.4. Key Takeaways

10. Europe Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. U.K.

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Europe

        10.2.2. By Service Type

        10.2.3. By Phase

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Service Type

        10.3.3. By Phase

    10.4. Key Takeaways

11. Asia Pacific Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. China

            11.2.1.2. Japan

            11.2.1.3. South Korea

            11.2.1.4. Malaysia

            11.2.1.5. Singapore

            11.2.1.6. Australia

            11.2.1.7. Rest of Asia Pacific

        11.2.2. By Service Type

        11.2.3. By Phase

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Service Type

        11.3.3. By Phase

    11.4. Key Takeaways

12. MEA Clinical Trial Kits Market Analysis 2015-2021 and Forecast 2022-2032, By Country

    12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        12.2.1. By Country

            12.2.1.1. GCC Countries

            12.2.1.2. South Africa

            12.2.1.3. Israel

            12.2.1.4. Rest of MEA

        12.2.2. By Service Type

        12.2.3. By Phase

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Service Type

        12.3.3. By Phase

    12.4. Key Takeaways

13. Key Countries Clinical Trial Kits Market Analysis

    13.1. U.K.

        13.1.1. Pricing Analysis

        13.1.2. Market Share Analysis, 2021

            13.1.2.1. By Service Type

            13.1.2.2. By Phase

    13.2. Canada

        13.2.1. Pricing Analysis

        13.2.2. Market Share Analysis, 2021

            13.2.2.1. By Service Type

            13.2.2.2. By Phase

    13.3. Brazil

        13.3.1. Pricing Analysis

        13.3.2. Market Share Analysis, 2021

            13.3.2.1. By Service Type

            13.3.2.2. By Phase

    13.4. Mexico

        13.4.1. Pricing Analysis

        13.4.2. Market Share Analysis, 2021

            13.4.2.1. By Service Type

            13.4.2.2. By Phase

    13.5. Rest of Latin America

        13.5.1. Pricing Analysis

        13.5.2. Market Share Analysis, 2021

            13.5.2.1. By Service Type

            13.5.2.2. By Phase

    13.6. Germany

        13.6.1. Pricing Analysis

        13.6.2. Market Share Analysis, 2021

            13.6.2.1. By Service Type

            13.6.2.2. By Phase

    13.7. U.K.

        13.7.1. Pricing Analysis

        13.7.2. Market Share Analysis, 2021

            13.7.2.1. By Service Type

            13.7.2.2. By Phase

    13.8. France

        13.8.1. Pricing Analysis

        13.8.2. Market Share Analysis, 2021

            13.8.2.1. By Service Type

            13.8.2.2. By Phase

    13.9. Spain

        13.9.1. Pricing Analysis

        13.9.2. Market Share Analysis, 2021

            13.9.2.1. By Service Type

            13.9.2.2. By Phase

    13.10. Italy

        13.10.1. Pricing Analysis

        13.10.2. Market Share Analysis, 2021

            13.10.2.1. By Service Type

            13.10.2.2. By Phase

    13.11. Rest of Europe

        13.11.1. Pricing Analysis

        13.11.2. Market Share Analysis, 2021

            13.11.2.1. By Service Type

            13.11.2.2. By Phase

    13.12. China

        13.12.1. Pricing Analysis

        13.12.2. Market Share Analysis, 2021

            13.12.2.1. By Service Type

            13.12.2.2. By Phase

    13.13. Japan

        13.13.1. Pricing Analysis

        13.13.2. Market Share Analysis, 2021

            13.13.2.1. By Service Type

            13.13.2.2. By Phase

    13.14. South Korea

        13.14.1. Pricing Analysis

        13.14.2. Market Share Analysis, 2021

            13.14.2.1. By Service Type

            13.14.2.2. By Phase

    13.15. Malaysia

        13.15.1. Pricing Analysis

        13.15.2. Market Share Analysis, 2021

            13.15.2.1. By Service Type

            13.15.2.2. By Phase

    13.16. Singapore

        13.16.1. Pricing Analysis

        13.16.2. Market Share Analysis, 2021

            13.16.2.1. By Service Type

            13.16.2.2. By Phase

    13.17. Australia

        13.17.1. Pricing Analysis

        13.17.2. Market Share Analysis, 2021

            13.17.2.1. By Service Type

            13.17.2.2. By Phase

    13.18. Rest of Asia Pacific

        13.18.1. Pricing Analysis

        13.18.2. Market Share Analysis, 2021

            13.18.2.1. By Service Type

            13.18.2.2. By Phase

    13.19. GCC Countries

        13.19.1. Pricing Analysis

        13.19.2. Market Share Analysis, 2021

            13.19.2.1. By Service Type

            13.19.2.2. By Phase

    13.20. South Africa

        13.20.1. Pricing Analysis

        13.20.2. Market Share Analysis, 2021

            13.20.2.1. By Service Type

            13.20.2.2. By Phase

    13.21. Israel

        13.21.1. Pricing Analysis

        13.21.2. Market Share Analysis, 2021

            13.21.2.1. By Service Type

            13.21.2.2. By Phase

    13.22. Rest of MEA

        13.22.1. Pricing Analysis

        13.22.2. Market Share Analysis, 2021

            13.22.2.1. By Service Type

            13.22.2.2. By Phase

14. Market Structure Analysis

    14.1. Competition Dashboard

    14.2. Competition Benchmarking

    14.3. Market Share Analysis of Top Players

        14.3.1. By Regional

        14.3.2. By Service Type

        14.3.3. By Phase

15. Competition Analysis

    15.1. Competition Deep Dive

        15.1.1. Azenta Life Sciences

            15.1.1.1. Overview

            15.1.1.2. Product Portfolio

            15.1.1.3. Profitability by Market Segments

            15.1.1.4. Sales Footprint

            15.1.1.5. Strategy Overview

                15.1.1.5.1. Marketing Strategy

        15.1.2. Q2 Solutions

            15.1.2.1. Overview

            15.1.2.2. Product Portfolio

            15.1.2.3. Profitability by Market Segments

            15.1.2.4. Sales Footprint

            15.1.2.5. Strategy Overview

                15.1.2.5.1. Marketing Strategy

        15.1.3. Patheon (Thermo fisher scientific)

            15.1.3.1. Overview

            15.1.3.2. Product Portfolio

            15.1.3.3. Profitability by Market Segments

            15.1.3.4. Sales Footprint

            15.1.3.5. Strategy Overview

                15.1.3.5.1. Marketing Strategy

        15.1.4. LabCorp drug development

            15.1.4.1. Overview

            15.1.4.2. Product Portfolio

            15.1.4.3. Profitability by Market Segments

            15.1.4.4. Sales Footprint

            15.1.4.5. Strategy Overview

                15.1.4.5.1. Marketing Strategy

        15.1.5. Charles River Laboratories

            15.1.5.1. Overview

            15.1.5.2. Product Portfolio

            15.1.5.3. Profitability by Market Segments

            15.1.5.4. Sales Footprint

            15.1.5.5. Strategy Overview

                15.1.5.5.1. Marketing Strategy

        15.1.6. LabConnect

            15.1.6.1. Overview

            15.1.6.2. Product Portfolio

            15.1.6.3. Profitability by Market Segments

            15.1.6.4. Sales Footprint

            15.1.6.5. Strategy Overview

                15.1.6.5.1. Marketing Strategy

        15.1.7. Almac group

            15.1.7.1. Overview

            15.1.7.2. Product Portfolio

            15.1.7.3. Profitability by Market Segments

            15.1.7.4. Sales Footprint

            15.1.7.5. Strategy Overview

                15.1.7.5.1. Marketing Strategy

        15.1.8. Precision medicine group

            15.1.8.1. Overview

            15.1.8.2. Product Portfolio

            15.1.8.3. Profitability by Market Segments

            15.1.8.4. Sales Footprint

            15.1.8.5. Strategy Overview

                15.1.8.5.1. Marketing Strategy

        15.1.9. Cerba research

            15.1.9.1. Overview

            15.1.9.2. Product Portfolio

            15.1.9.3. Profitability by Market Segments

            15.1.9.4. Sales Footprint

            15.1.9.5. Strategy Overview

                15.1.9.5.1. Marketing Strategy

        15.1.10. Alpha Laboratories Ltd

            15.1.10.1. Overview

            15.1.10.2. Product Portfolio

            15.1.10.3. Profitability by Market Segments

            15.1.10.4. Sales Footprint

            15.1.10.5. Strategy Overview

                15.1.10.5.1. Marketing Strategy

        15.1.11. Marken SAS

            15.1.11.1. Overview

            15.1.11.2. Product Portfolio

            15.1.11.3. Profitability by Market Segments

            15.1.11.4. Sales Footprint

            15.1.11.5. Strategy Overview

                15.1.11.5.1. Marketing Strategy

        15.1.12. Clinigen

            15.1.12.1. Overview

            15.1.12.2. Product Portfolio

            15.1.12.3. Profitability by Market Segments

            15.1.12.4. Sales Footprint

            15.1.12.5. Strategy Overview

                15.1.12.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology